J Clin Immunol (2015) 35:696–726 DOI 10.1007/s10875-015-0201-1 ORIGINAL RESEARCH Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 Capucine Picard 1,2 & Waleed Al-Herz 3,4 & Aziz Bousfiha 5 & Jean-Laurent Casanova 1,6,7,8,9 & Talal Chatila 10 & Mary Ellen Conley 6 & Charlotte Cunningham-Rundles 11 & Amos Etzioni 12 & Steven M. Holland 13 & Christoph Klein 14 & Shigeaki Nonoyama 15 & Hans D. Ochs 16 & Eric Oksenhendler 17,18 & Jennifer M. Puck 19 & Kathleen E. Sullivan 20 & Mimi L K. Tang 21,22,23 & Jose Luis Franco 24 & H. Bobby Gaspar 25 Received: 20 July 2015 / Accepted: 20 September 2015 / Published online: 19 October 2015 # The Author(s) 2015. This article is published with open access at Springerlink.com Abstract We report the updated classification of primary immunodeficiencies compiled by the Primary Immunodeficiency Expert Committee (PID EC) of the International Union of Immunological Societies (IUIS). In the two years since the previous version, 34 new gene defects are reported in this updated version. For each disorder, the key clinical and laboratory features are provided. In this new version we continue to see the increasing overlap between immunodeficiency, as * H. Bobby Gaspar h.gaspar@ucl.ac.uk 12 Meyer Children’s Hospital-Technion, Haifa, Israel 13 Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA 14 Dr von Hauner Children’s Hospital, Ludwig-Maximilians-University Munich, Munich, Germany 15 Department of Pediatrics, National Defense Medical College, Saitama, Japan 16 Department of Pediatrics, University of Washington and Seattle Children’s Research Institute, Seattle, WA, USA 17 Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France 18 Université Paris Diderot, Sorbonne Paris Cité, Paris, France 19 Department of Pediatrics, University of California San Francisco and UCSF Benioff Children’s Hospital, San Francisco, CA, USA 20 Division of Allergy Immunology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA 21 Murdoch Childrens Research Institute, Melbourne, VIC, Australia 22 Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia 1 Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France 2 Centre d’étude des déficits immunitaires (CEDI), Hôpital Necker-Enfants Malades, AP-HP, Paris, France 3 Department of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait 4 Allergy and Clinical Immunology Unit, Department of Pediatrics, Al-Sabah Hospital, Kuwait City, Kuwait 5 Clinical Immunology Unit, Casablanca Children’s Hospital, Ibn Rochd Medical School, King Hassan II University, Casablanca, Morocco 6 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA 7 Howard Hughes Medical Institute, New York, NY, USA 8 University Paris Descartes, Imagine Institute, Paris, France 9 Pediatric Hematology & Immunology Unit, Necker Hospital for Sick Children, Paris, France 23 Department of Allergy and Immunology, Royal Children’s Hospital, Melbourne, Australia 10 Division of Immunology, Children’s Hospital Boston, Boston, MA, USA 24 Group of Primary Immunodeficiencies, University of Antioquia, Medellin, Colombia 11 Department of Medicine and Pediatrics, Mount Sinai School of Medicine, New York, NY, USA 25 UCL Institute of Child Health, 30, Guilford Street, London WC1N 1EH, UK J Clin Immunol (2015) 35:696–726 manifested by infection and/or malignancy, and immune dysregulation, as manifested by auto-inflammation, auto-immunity, and/or allergy. There is also an increased number of genetic defects that lead to susceptibility to specific organisms which reflects the finely tuned nature of immune defense systems. This classification is the most up to date catalogue of all known and published primary immunodeficiencies and acts as a current reference of the knowledge of these conditions and is an important aid for the genetic and molecular diagnosis of patients with these rare diseases. Keywords Primary immunodeficiencies . classification . genetic defects Background The International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency met in London on the 14th and 15th March 2015 to update the classification of human primary immunodeficiencies (PIDs). This report represents the most current and complete catalogue of known PIDs. It serves as a reference for these conditions and provides a framework to help in the diagnostic approach to patients suspected to have PID. As in previous reports, we have classified the conditions into major groups of PIDs and these are now represented in 9 different tables (Tables 1, 2, 3, 4, 5, 6, 7,8 and 9). In each table, we list the condition, its genetic defect if known and the major immunological and in some conditions the non-immunological abnormalities associated with the disease. This year we have added the gene OMIM number as well as the phenotype OMIM number for ease of reference. The classification this year differs in a number of ways from the previous edition published in 2014. Importantly, each defect is now listed in only one table. The diverse immunological phenotypes of many conditions imply that a very large number of conditions could very readily be listed in multiple tables. However, with the increasing number of identified defects, this would make each table large and cumbersome. For this reason, we chose to list each defect in one table only and to place it according to the most pronounced and fundamental defect. For this reason and as an example, CD40L deficiency is now found in Table 1 amongst combined immunodeficiencies, because CD40L is a T cell signaling molecule whose absence leads to both cellular and humoral defects, even though it was originally described as an antibody deficiency. Although some of our placements may be disputed, the committee came to these decisions after much thought and deliberation. 697 The title of Table 6 has now been slightly changed to ‘Defects in intrinsic and innate immunity’ and contains defects characterized by susceptibility to specific organisms. For this reason, the MSMDs (Mendelian Susceptibility to Mycobacterial Disease) are now in Table 6, having previously been in Table 5 (Phagocytic Disorders). In previous editions, we have placed an asterisk against conditions in which 10 or fewer individuals had been described in the literature. However, this is now felt to be an artificial indicator as, once described, a condition may be found in additional patients but not necessarily reported. For this reason, there is no specific indicator of the number of patients identified or reported. There is a growing appreciation of wide phenotypic variability for many of the individual specific gene defects, reflecting not only the variety of mutations within each gene but also host and/or environmental modifying factors that may impact the phenotype even between individuals with the same mutation within the same gene. The complexities of these conditions in terms of clinical and immunological presentation and heterogeneity cannot easily be captured in the limited space of a table format. For this reason, the furthest right column contains the Online Mendelian Inheritance in Man (OMIM) reference for each condition to allow access to a source of greater detail and updated information as to the phenotype. A number of the new genes included in this edition of the classification tables are molecules associated not only with the immune system, but also with more generic cellular functions; such defects result in both immunological and nonimmunological abnormalities. In addition, there are a number of gain-of-function (GOF) mutations identified such as in PIK3CD. In CARD11 and STAT1 for example, there are both autosomal dominant GOF and autosomal recessive loss of function variants and these different modes of inheritance in the same gene lead to different functional consequences and hence different immunological and clinical phenotypes. The other trend that is increasingly observed is the increase in disorder of immunedysregulation rather than pure immunodeficiency. The goal of the IUIS Expert Committee on Primary Immunodeficiencies is to increase awareness, facilitate recognition and promote optimal treatment for patients with Primary Immunodeficiencies. In addition to the current report and previous ‘classification table’ publications, the committee has also produced a ‘Phenotypic Approach for IUIS PID classification and Diagnosis: Guidelines for Clinicians at the Bedside,’ which aims to lead physicians to particular groups of PIDs starting from clinical features and combining routine immunological investigations. This will be further updated to include the newly identified defects. Together these contributions will hopefully allow a practical clinical framework for PID diagnosis. Genetic defect/Presumed pathogenesis Gene OMIM Mutation of IL2RG Defect in γ chain of receptors for IL-2, -4, -7, -9, -15, -21 308380 Mutation of JAK3 Defect in Janus activating kinase 3 600173 Mutation of IL7RA Defect in IL-7 receptor α chain 146661 Mutation of PTPRC Defect in CD45 151460 Mutation of CD3D Defect in CD3δ, chain of T cell antigen receptor complex 186790, Mutation of CD3E Defect in CD3ε chain of T cell antigen receptor complex 186830, Mutation of CD3Z Defect in CD3ζ chain of T cell antigen receptor complex 186780 Mutation of CORO1A Defective thymic egress of T cells and defective T cell locomotion 605000 Markedly decreased Markedly decreased Markedly decreased Markedly decreased Markedly decreased Markedly decreased Markedly decreased Markedly decreased XL AR AR AR AR AR AR AR Inheritance Circulating T cells RAG 2 deficiency RAG 1 deficiency Mutation of RAG1 Defective VDJ recombination; defect of recombinase activating gene (RAG) 1 179615 Mutation of RAG2 Defective VDJ recombination; Markedly decreased Markedly decreased AR AR DNA recombination defects (for additional DNA repair defects see Table 2) T−B− SCID Coronin-1A deficiency CD3ζ deficiency CD3ε deficiency CD3δ deficiency CD45 deficiency IL7Rα deficiency JAK3 deficiency γc deficiency T−B+ Severe Combined Immunodeficiency (SCID) Disease Table 1 Immunodeficiencies affecting cellular and humoral immunity Markedly decreased Markedly decreased Normal Normal Normal Normal Normal Normal or increased Normal or increased Normal or increased Circulating B cells Decreased Decreased Decreased Decreased Decreased Decreased Decreased Decreased Decreased Decreased Serum Ig Detectable thymus EBV-associated B-cell lymphoproliferation Normal NK cells No γ/δ T cells Normal NK cells No γ/δ T cells 601457 601457 615401 610163 615615 615617 608971 Normal γ/δ T cells Normal NK cells No γ/δ T cells 608971 600802 300400 Phenotype OMIM number Normal NK cells Markedly decreased NK cells; Markedly decreased NK cells; Associated Features 698 J Clin Immunol (2015) 35:696–726 defect of recombinase activating gene (RAG) 2 179616 Mutation of ARTEMIS Defective VDJ recombination; defect in Artemis DNA recombinase-repair protein 605988 Mutation of PRKDC Defective VDJ recombination; defect in DNA PKcs Recombinase repair protein 600899 Mutation of Cernunnos Defective VDJ recombination; defect in Cernunnos 611290 Mutation of LIG4 Defective VDJ recombination; defect in DNA ligase IV 601837 Mutation of AK2 Defective maturation of lymphoid and myeloid cells (stem cell defect) Defect in mitochondrial adenylate kinase 2. 103020 Mutation of ADA Absent ADA activity, elevated lymphotoxic metabolites (dATP, S-adenosyl homocysteine) 608958 Genetic defect/Presumed pathogenesis Gene OMIM Markedly decreased Markedly decreased Markedly decreased Markedly decreased Markedly decreased Absent from birth (null mutations) or progressive decrease AR AR AR AR AR AR Inheritance Circulating T cells DOCK2 deficiency Mutations in DOCK2 required for RAC1 activation, actin polymerization, T-cell proliferation, chemokine-induced lymphocyte migration and NK-cell degranulation 603122 AR Decreased. Poor response to PHA. Low TRECs Combined immunodeficiencies generally less profound than severe combined immunodeficiency Adenosine deaminase (ADA) deficiency Reticular dysgenesis, AK2 deficiency DNA ligase IV deficiency Cernunnos/XLF deficiency DNA PKcs deficiency DCLRE1C (Artemis) deficiency Disease Table 1 (continued) Normal Absent from birth of progressive decrease Decreased or normal Markedly decreased Markedly decreased Markedly decreased Markedly decreased Circulating B cells Decreased/ Normal. Poor antibody responses Progressive decrease Decreased Decreased Decreased variable Decreased Serum Ig Normal NK numbers, but defective function. Impaired interferon responses in hematopoietic and non-hematopoietic cells Decreased NK cells, often with costochondral junction flaring, neurological features, hearing impairment, lung and liver manifestations; partial ADA deficiency may lead to delayed or milder presentation Granulocytopenia and deafness Radiation sensitivity, microcephaly and developmental defects Radiation sensitivity, microcephaly and developmental defects Radiation sensitivity, microcephaly and developmental defects Autoimmunity and granuloma Radiation sensitivity Associated Features 616433 102700 267500 606593 611291 615966 602450 Phenotype OMIM number J Clin Immunol (2015) 35:696–726 699 Mutation in transcription factors for MHC class II proteins (CIITA gene) 600005 MHC class II deficiency group A MHC class I deficiency MHC class I deficiency MHC class I deficiency MHC class I deficiency ZAP-70 deficiency CD8 deficiency CD3γ deficiency ICOS deficiency CD40 deficiency Mutation of CD40LG Defects in CD40 ligand (CD40L; also called TNFSF5 or CD154) cause defective isotype switching and impaired dendritic cell signaling 300386 Mutation of CD40 (also called TNFRSF5) Defects in CD40 cause defective isotype switching and impaired dendritic cell signaling 109535 Mutations in ICOS; a co-stimulatory molecule expressed on T cells 604558 Mutation of CD3G. Defect in CD3γ component of the T cell antigen receptor complex 186740 Mutation of CD8A. Defects of CD8 α chain, important for maturation and function of CD8 T cells 186910 Mutation in ZAP70 intracellular signaling kinase, acts downstream of TCR 176947 Mutations in TAP1, gene, causing MHC class I non-expression 170260 Mutations in TAP2, gene, causing MHC class I non-expression 170261 Mutations in TAPBP (tapasin) gene, causing MHC class I non-expression 601962 Mutations in B2M gene, causing MHC class I non-expression 109700 Genetic defect/Presumed pathogenesis Gene OMIM CD40 ligand deficiency Disease Table 1 (continued) Normal Normal, but reduced TCR expression Absent CD8, normal CD4 cells Decreased CD8, normal CD4 cells Decreased CD8, normal CD4 cells; absent MHC I expression on lymphocytes Decreased CD8, normal CD4 cells; absent MHC I expression on lymphocytes Decreased CD8, normal CD4 cells; absent MHC I expression on lymphocytes Decreased CD8, normal CD4 cells; absent MHC I expression on lymphocytes AR AR AR AR AR AR AR AR Decreased CD4 cells Absent MHC II expression on lymphocytes Normal AR AR IgM increased or normal, other isotypes decreased sIgM+ and sIgD+ B cells present, other surface isotype positive B cells absent Normal; may progressively decrease XL Normal Normal Normal Normal Normal Normal Normal or decreased Normal Normal Normal Normal Normal Normal Low Normal Normal Normal Normal IgM+ and IgD+ B cells present, IgM increased or other isotypes absent normal, other isotypes decreased Serum Ig Circulating B cells Inheritance Circulating T cells 604571 604571 604571 269840 615607 607594 606843 308230 Phenotype OMIM number Sinopulmonary infections, cutaneous not yet assigned granuloma, hypoproteinemia. Absent expression of β2m associated proteins like MHC-I, CD1a, and CD1b, CD1c on β2mdeficient cells Failure to thrive, diarrhea, respiratory 209920 tract infections liver/biliary tract disease Vasculitis; pyoderma gangrenosum Vasculitis; pyoderma gangrenosum Vasculitis; pyoderma gangrenosum Autoimmunity in some cases Recurrent infections; autoimmunity, gastroenteritis, may have granulomas Neutropenia, gastrointestinal and liver/biliary tract disease, opportunistic infections Neutropenia, thrombocytopenia; hemolytic anemia, biliary tract and liver disease, opportunistic infections Associated Features 700 J Clin Immunol (2015) 35:696–726 Normal or decreased Normal Decreased CD4 cells Absent MHC II expression on lymphocytes Progressive decrease AR AR AR AR Defects in LCK – a proximal tyrosine kinase that interacts with TCR 153390 Mutations in MALT1 – LCK deficiency MALT1 deficiency TCRα deficiency AR AR AR AR XL Normal or decreased Normal Decreased CD4 cells Absent MHC II expression on lymphocytes AR Normal All CD3 T cells expressed TCRγδ (or may be better to say: TCRαβ T-cell deficiency), impaired T cells proliferation Normal total numbers but CD4+ T-cell lymphopenia, low Treg numbers, restricted T cell repertoire and impaired TCR signaling Normal low naïve T cells and RTE, restricted T cell repertoire and impaired T cells proliferation in response to CD3 stimulation. Decreased increased proportion of terminal differentiated effector memory cells (TEMRA), low naïve T cells, restricted T cell repertoire in the TEMRA population and impaired T cells proliferation Normal Normal Normal Decreased Normal Decreased CD4 cells reduced numbers Normal of RTE, impaired T-cell proliferation in response to CD3 Decreased; low Decreased; Impaired T lymphocyte CD27+ memory proliferation; Treg deficiency B cells and poor function Normal Normal IgG and IgA and increased IgM Normal High 209920 Phenotype OMIM number EBV associated B cell lymphoproliferation, lymphoma Normal or decreased IgG Bacterial, fungal and viral infections Diarrhea, recurrent infections, immune dysregulation autoimmunity, Recurrent bacterial, viral, and candidal infections; intermittent neutropenia; EBV-driven lymphoproliferation; lymphoma; Congenital heart disease, autoimmune cytopenias; HPV infection. Recurrent viral, bacterial and fungal infections, immune dysregulation autoimmunity, and diarrhea. 615468 615758 615387 614868 not yet assigned 243700 300853 613011 Failure to thrive, diarrhea, respiratory 209920 tract infections liver/biliary tract disease Failure to thrive, diarrhea, respiratory 209920 tract infections liver/biliary tract disease Failure to thrive, diarrhea, respiratory tract infections liver/biliary tract disease Associated Features EBV infection, lymphoma; viral infections, respiratory and GI infections, Low IgM, increased IgE Decreased NK cells with impaired f unction, hypereosinophilia, recurrent infections; severe atopy, extensive cutaneous viral and staphylococcal infections, susceptibility to cancer. Defects in peripheral B tolerance. Normal HPV infection, lymphoma, lung granulomas, molluscum contagiosum, Normal Normal or decreased Normal or decreased Normal Decreased CD4 cells Absent MHC II expression on lymphocytes AR Normal Serum Ig Circulating B cells Inheritance Circulating T cells Mutations in TRAC – essential component of the T cell receptor 186880 MST1 deficiency RhoH deficiency DOCK8 deficiency MAGT1 deficiency ITK deficiency MHC class II deficiency group D Mutations in RHOH – an atypical Rho GTPase transducing signals downstream of various membrane receptors 602037 Mutations in STK4 – a serine/ threonine kinase 604965 Mutation in transcription factors for MHC class II proteins RFXANK gene 603200 Mutation in transcription factors for MHC class II proteins RFX5, gene) 601863 Mutation in transcription factors for MHC class II proteins (RFXAP gene 601861 Mutations in ITK encoding IL-2 inducible T cell kinase required for TCR-mediated activation 186973 Mutations in MAGT1, Impaired Mg++ flux leading to impaired TCR signaling 300715 Mutations in DOCK8 encoding a dedicator of cytokinesis regulator of intracellular actin reorganisation 611432 MHC class II deficiency group B MHC class II deficiency group C Genetic defect/Presumed pathogenesis Gene OMIM Disease Table 1 (continued) J Clin Immunol (2015) 35:696–726 701 CTPS1 deficiency NIK deficiency CD27 deficiency LRBA deficiency IKBKB deficiency OX40 deficiency IL-21R deficiency IL-21 deficiency BCL10 deficiency CARD11 deficiency Disease Table 1 (continued) Mutation in CTPS1, encoding CTP synthase 1, essential for lymphocyte proliferation 123860 a caspase-like cysteine protease that is essential for nuclear factor-kappa-B activation 604860 Defects in CARD11 – acts as a scaffold for NF-9B activity in the adaptive immune response 607210 Mutations in BCL10 which encodes the B cell CLL / lymphoma 10 protein that forms a heterotrimer with Malt1 and CARD family adaptors and plays a role in NF-kB signaling 603517 Mutation in IL21 605384 Defects in IL21R – together with common gamma chain binds IL-21 605383 Defects in OX40 (TNFRSF4) encoding a co-stimulatory molecule expressed on activated T cells 600315 Defects in IKBKB, encoding IkB 2 kinase 2, a component of the NF-kB pathway 603258 Mutations in LRBA (lipopolysaccharide responsive beige-like anchor protein) 606453 Mutations in CD27 (TNFRSF7) encoding TNF-R member superfamily required for generation and long-term maintenance of T cell immunity 186711 Mutation in MAP3K14, encoding NIK (NF-kB-inducing kinase) 604655 Genetic defect/Presumed pathogenesis Gene OMIM Normal Normal number; impaired proliferation Decreased total peripheral B cell and switched in response to antigen stimulation. memory B cells Polycloncal Vβ repertoires Normal or decreased number Normal or decreased proliferation AR AR AR Normal/low number No memory B cells Normal or decreased CD4 numbers; T cell dysregulation AR Low or normal numbers of B cells Normal total T cells; absent regulatory Normal B cell numbers; impaired BCR activation; and +% T cells; impaired TCR activation AR Normal/high IgG Recurrent bacterial, viral and Cryptosporidium infections. Low NK cell number and defective NK cell activation Recurrent/chronic viral infections specially EBV and VZV, bacterial infections, EBV-driven B-cell non-Hodgkin lymphoma Hypogammaglobulinaemia 615897 Not yet assigned 615122 Clinical and immunologic features triggered by EBV infection, HLH Aplastic anaemia, Lymphoma, hypogammaglobulinemia, Low iNKT cells Hypogammaglobulinaemia following EBV infection 615592 614700 Recurrent bacterial, viral and f ungal infections; clinical phenotype of SCID 615593 615207 615767 616098 615206 Phenotype OMIM number Recurrent infections, inflammatory bowel disease, autoimmunity; EBV infections Reduced I IgG and IgA in most Decreased Kaposi’s sarcoma; impaired immunity to HHV8 Normal Normal B cell numbers; reduced frequency of memory B cells Normal T cell numbers; decreased antigen specific memory CD4+ cells Suspectibility to cryptoporidia and pneumocystis and cholangitis Normal but impaired specific responses Normal AR AR Severe early onset colitis IgG deficiency Low Recurrent bacterial and viral infections, candidiasis, gastroenteritis Low Normal number; decreased memory and switched B cells Normal number. Normal/low function Abnormal T cell cytokine production; Abnormal T cell proliferation to specific stimuli Normal numbers, low memory T and Tregs, decreased proliferation to antigen and antiCD3 AR Pneumocystis jirovicii pneumonia, bacterial infections, Associated Features Absent/low Impaired antibody response Serum Ig Normal predominance of transitional B lymphocytes, Circulating B cells AR Normal predominance of naive T-lymphocyte, impaired T cells proliferation AR Normal number but impaired T cells proliferation Inheritance Circulating T cells 702 J Clin Immunol (2015) 35:696–726 Hypomorphic mutations in RAG1, RAG2, Artemis, IL7RA, RMRP, ADA, DNA Ligase IV, IL2RG, AK2, or associated with DiGeorge syndrome; some cases have no defined gene mutation Genetic defect/Presumed pathogenesis Gene OMIM Present; restricted T cell repertoire and impaired function Inheritance Circulating T cells Normal or decreased Circulating B cells Decreased, except for increased IgE Serum Ig Erythroderma, eosinophilia, adenopathies, hepatosplenomegaly Associated Features 603554 Phenotype OMIM number XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, SCID severe combined immune deficiency, EBV epstein barr virus, Ca++ calcium, MHC major histocompatibility complex, RTE recent thymic emigrants, HPV human papillomavirus UNC119 deficiency has been removed from this version of the classification tables, as the UNC119 variant reported previously has been identified as a polymorphism in unaffected individuals (Gorska MM, Alam R. A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia. Blood. 2012 Feb 9;119(6):1399–406. doi: 10.1182/blood-2011-04350686. Epub 2011 Dec 19). See Erratum (Blood. 2014 Jan 16;123(3):457) Notes: Infants with SCID who have maternal T cell engraftment may have allogeneic T cells present even in normal numbers, but that do not function normally; these cells may cause autoimmune cytopenias or graft versus host disease. Hypomorphic mutations in several of the genes that when affected by null mutations cause SCID may result in Omenn syndrome (OS), or “leaky” SCID or a less profound combined immunodeficiency or CID phenotype. Both OS and leaky SCID can be associated with >300 autologous T cells/uL of peripheral blood and reduced rather than absent proliferative responses; Individuals with partially defective, or leaky, mutations are generally more mildly affected compared with those with typical SCID caused by null mutations. A spectrum of clinical findings including typical SCID, OS, leaky SCID, CID, granulomas with T lymphopenia, autoimmunity and CD4+ T lymphopenia can be found in an allelic series of RAG1 and other SCID associated genes. RAC2 deficiency is a disorder of leukocyte motility and is reported in Table 5; however, one patient with RAC2 deficiency had absent T cell receptor excision circles (TRECs) by newborn screening, though T cell numbers and mitogen responses were not impaired. For additional syndromic conditions with T cell lymphopenia, such as DNA repair defects, cartilage hair hypoplasia, IKAROS deficiency and NEMO syndrome, see Tables 2 and 6; however, it should be noted that individuals with the most severe manifestations of these disorders could have clinical signs and symptoms of SCID New genes added: DOCK2, B2M, IL21, MAP3K14, CTPS1 Total no. of genes in Table 1: 49 Omenn syndrome Disease Table 1 (continued) J Clin Immunol (2015) 35:696–726 703 Mutations in WAS; cytoskeletal and immunologic synapse defect affecting haematopoietic stem cell derivatives 301000 Genetic defect/Presumed pathogenesis OMIM number gene locus Hypomorphic mutations in NBS1 (Nibrin); disorder of cell cycle checkpoint and DNA double- strand break repair 602667 Mutations in BLM (RECQL3); encoding DNA helicase RecQ protein-like 3 helicase 604610 Mutations in DNA methyltransferase DNMT3B (ICF1) resulting i n defective DNA methylation 602900; Mutations in ZBTB24 (ICF2) 614064 Mutations in PMS2, resulting i n Class Switch recombination deficiency due to impaired mismatch repair 600259 Mutations in RNF168, resulting in defective DNA double-strand break repair (RIDDLE syndrome) 612688 Mutations in MCM4 (minichromosome maintenance complex component 4) gene involved in DNA replication and repair Nijmegen breakage syndrome Immunodeficiency with centromeric instability and facial anomalies (ICF2) PMS2 deficiency MCM4 deficiency RNF168 deficiency Immunodeficiency with centromeric instability and facial anomalies (ICF1) Bloom syndrome Mutations in ATM; disorder of cell cycle check-point and DNA double- strand break repair 607585 Ataxia-telangiectasia Mutations in WIPF1; cytoskeletal and immunologic synapse defect affecting haematopoietic stem cell derivatives 602357 2. DNA repair defects (other than those in Table 1) WIP deficiency Wiskott-Aldrich syndrome (WAS) 1. Congenital thrombocytopenia Disease Decreased or normal; responses to PHA may be decreased AR Normal Normal AR Normal AR AR Decreased or normal; Responses to PHA may be decreased Normal AR AR Progressive decrease Progressive decrease, abnormal proliferation to mitogens AR AR Normal Normal Reduced B cells, switched a nd non-switched Decreased or normal Decreased or normal Normal Variably reduced Normal Reduced, Defective lymphocyte Low responses to anti-CD3 AR Normal numbers Circulating B cells Progressive decrease, Abnormal lymphocyte responses to anti-CD3 Circulating T cells XL Inheritance Table 2 Combined immunodeficiencies with associated or syndromic features Normal Low IgG, IgM, or low IgA Low IgG and IgA, elevated IgM, abnormal antibody responses Hypogammaglobulinemia; variable antibody deficiency Hypogammaglobulinemia; variable antibody deficiency Often decreased IgA, IgE and IgG subclasses; increased IgM monomers; antibodies variably decreased Often decreased IgA, IgE and IgG subclasses; increased IgM; antibodies variably decreased Reduced Normal, except for increased IgE Decreased IgM: antibody to polysaccharides particularly decreased; often increased IgA and IgE Serum Ig Short stature; mild defect of motor control to ataxia; normal intelligence to learning difficulties; mild facial dysmorphism to microcephaly; increased radiosensitivity Viral infections (EBV, HSV, VZV) Adrenal failure Short stature Low NK cells Short stature; bird like face; sunsensitive erythema; marrow failure; leukemia; lymphoma; chromosomal instability Facial dysmorphic features; macroglossia; bacterial/opportunistic infections; malabsorption; cytopenias; malignancies; multiradial configurations of chromosomes 1, 9, 16; no DNA breaks Facial dysmorphic features; macroglossia; bacterial/opportunistic infections; malabsorption; cytopenias; malignancies; multiradial configurations of chromosomes 1, 9, 16; Recurrent infections; café-au-lait spots; lymphoma, colorectal carcinoma, brain tumor Microcephaly; bird-like face; lymphomas; solid tumors; increased radiosensitivity; chromosomal instability Ataxia; telangiectasia; pulmonary infections; lymphoreticular and other malignancies; increased alpha fetoprotein and increased radiosensitivity; chromosomal instability Thrombocytopenia with small platelets; eczema; lymphoma; autoimmune disease; IgA nephropathy; bacterial and viral infections. XL thrombocytopenia is a mild form of WAS, and XL neutropenia is caused by missense mutations in the GTPase binding domain of WASP Recurrent infections; eczema; thrombocytopenia. WAS-like phenotype. Associated features 609981 611943 276300 614069 242860 210900 251260 208900 614493 300392 OMIM number Phenotype 704 J Clin Immunol (2015) 35:696–726 Genetic defect/Presumed pathogenesis OMIM number gene locus PGM3 deficiency AR CD8 and CD4 T cells may be decreased Normal AR Comel-Netherton syndrome Mutations in SPINK5 resulting in lack of the serine protease inhibitor LEKTI, expressed in epithelial cells 605010 Normal overall Th-17 and T-follicular helper cells decreased AD Often de novo mutation AD-HIES (Job or Buckley Syndrome) Dominant-negative heterozygous mutations in signal transducer and activator of transcription STAT3 102582 5. Hyper-IgE syndromes (HIES) Decreased AR Mutations in SMARCAL1; involved in chromatin remodeling 606622 Markedly decreased AR Schimke Immunoosseous Dysplasia Decreased or normal; response to PHA may be decreased De novo haplo-insufficiency (majority) or AD Varies from severely decreased (SCID) to normal; impaired lymphocyte proliferation Decreased or normal; response to PHA may be decreased De novo haplo-insufficiency (majority) or AD AR Decreased or normal; 5 % have <1500 CD3 T cells/uL in neonatal period De novo haplo-insufficiency (majority) or AD; phenocopies may have other as yet undefined genetic lesions Circulating T cells Mutations in RMRP (RNase MRP RNA) Involved in processing of mitochondrial RNA and cell cycle control 157660 Contiguous gene deletion in chromosome 22q11.2 or mutation of a gene within this deletion region, TBX1, encoding a transcription factor critical for development of thymus and adjacent embryonic structures 602054 Variable defects of the thymus and associated T cell abnormalities, often due to deletions or mutations in transcription regulator CHD7, 608892 Variable defects of the thymus and associated T cell abnormalities, often due to deletions or mutations in transcription regulator, or semaphorin SEMA3E 608166 Defects in forkhead box N1 transcription factor encoded by FOXN1 600838 Inheritance Cartilage hair hypoplasia 4. Immune-osseous dysplasias Winged helix deficiency (nude) AAB: syndromic SCID CHARGE syndrome due to SEMA3E defects CHARGE syndrome due to CHD7 defects DiGeorge syndrome* 602638 3. Thymic defects with additional congenital anomalies Disease Table 2 (continued) Normal or decreased Normal Reduced B and memory B cells Switched and non-switched B cells are reduced Normal; reduced switched and non-switched memory B cells; BAFF expression increased Normal Normal Elevated IgE and IgA Antibody variably decreased Elevated IgE; specific antibody production decreased Normal Normal or reduced antibodies variably decreased Decreased Normal or decreased Normal Normal Normal or decreased Serum Ig Normal Circulating B cells Distinctive facial features (broad nasal bridge), bacterial infections (boils and pulmonary abscesses, pneumatoceles) due to S. aureus, aspergillus, Pneumocystis jirovecii; eczema, mucocutaneous candidiasis, hyperextensible joints, osteoporosis and bone fractures, scoliosis, retention of primary teeth, aneurysm formation Congenital ichthyosis, bamboo hair, atopic diathesis, increased bacterial infections, failure to thrive Short-limbed dwarfism with metaphysealdysostosis, sparse hair, bone marrow failure, autoimmunity, susceptibility to lymphoma and other cancers, impaired spermatogenesis, neuronal dysplasia of the intestine Short stature, spondiloepiphyseal dysplasia, intrauterine growth retardation, nephropathy; bacterial, viral, fungal infections; may present as SCID; bone marrow failure Alopecia; nail dystropphy; severe infections abnormal thymic epithelium, impaired T cell maturation Coloboma, heart anomaly, choanal atresia, mental retardation, genital and ear anomalies; some are SCID-like and have low TRECs Coloboma, heart anomaly, choanal atresia, mental retardation, genital and ear anomalies; some are SCID-like and have low TRECs Hypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability and other abnormalities; often with 3 Mb interstitial deletion in 22q11.2 (or rarely with intragenic mutation of TBX1, deletion in 10p) Associated features 615816 256500 147060 242900 250250 601705 214800 214800 188400 OMIM number Phenotype J Clin Immunol (2015) 35:696–726 705 Genetic defect/Presumed pathogenesis OMIM number gene locus Inheritance Mutation in TINF2 encoding telomerase interacting factor 2 604319 AD-DKC due to TINF2 deficiency AD/AR -DKC due to TPP1 deficiency Mutation in adrenocortical dysplasia homolog (ACD) encoding TPP1 affecting the TELpatch domain resulting in failure to recruit telomerase to telomers 609377 AR-DKC due to DCLRE1B Mutation in DCLRE1B/ SNM1/ deficiency APOLLO: DNA CROSS-LINK REPAIR PROTEIN 1B 609683 Mutation in TERT encoding telomerase reverse transcriptase 187270 AD-DKC due to TERT deficiency AD-DKC due to TERC deficiency AR-DKC due to regulator of telomere elongation (RTEL1) deficiency AR AR Variable AD/AR Variable AD or AR Variable Variable AD AD Decreased Decreased AD or AR AR Decreased AR Mutations in NOLA2 (NHP2), component of the H/ACA ribonucleo-protein complex 606470 Mutation in NOLA3 (NOP10, PCFT), a component of the H/ACA ribonucleoprotein complex 606471 Mutation in RTEL1 encoding regulator of telomere elongation helicase 1 (RTEL1) 608833 Mutation in TERC encoding telomerase RNA component 602322 AR-DKC due to nucleolar protein family A member 2 (NHP2) deficiency AR-DKC due to nucleolar protein family A member 3 (NHP3) or NOP10 deficiency Progressive decrease XL Mutations in DKC1 encoding dyskerin 300126 Circulating T cells XL-DKC due to Dyskerin deficiency Mutations inphosphoglycomutase 3 (PGM3) associated with a glycosylationand atopy 172100 6. Dyskeratosis congenita (DKC) with bone marrow failure and dysfunctional telomere maintenance Disease Table 2 (continued) Variable Variable Variable Variable Variable Variable Variable Progressive decrease Circulating B cells Variable Variable Variable Variable Variable Variable Variable Reticular hyperpigmentation of the skin, dystrophic nails, osteoporosis premalignant leukokeratosis of the oral mucosa, palmar hyperkeratosis, anemia, pancytopenia. May present as HHS Reticular hyperpigmentation of the skin, dystrophic nails, osteoporosis premalignant leukokeratosis of the oral mucosa, palmar hyperkeratosis, anemia, pancytopenia. AD version is milder than the AR version which can resemble HHS Reticular hyperpigmentation of the skin, dystrophic nails, osteoporosis premalignant leukokeratosis of the oral mucosa, palmar hyperkeratosis, anemia, pancytopenia. May present as HHS Reticular hyperpigmentation of the skin, dystrophic nails, osteoporosis leukoplakia of the oralmucosa, carcinoma, leukemia palmar hyperkeratosis, anemia, pancytopenia. May present as HHS dyskeratosis congenita and Hoyeraal-Hreidarsson (HH) syndrome Pancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, hypoplastic/dysplastic nails. May present as HHS Pancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, hypoplastic/ dysplastic nails Intrauterine growth retardation, microcephaly, nail dystrophy, recurrent infections, digestive tract involvement, pancytopenia, reduced number and function of NK cells. A severe phenotype with developmental delay and cerebellar hypoplasia is known as HoyeraalHreidarsson Syndrome (HHS) Pancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, hypoplastic/dysplastic nails Severe atopy, autoimmunity, bacterial and viral infections, cognitive impairment, hypomyelination Normal or elevated Ig’s, elevated IgE; eosinophilia Variable hypogammaglobulinemia Associated features Serum Ig 616353 616353 613990 613989 127550 615190 224230 613987 305000 OMIM number Phenotype 706 J Clin Immunol (2015) 35:696–726 Normal (decreased memory T cells) Low naïve T cells; decreased T cell proliferation AR Mutation in POLE1; Defective DNA replication 174762 Facial dysmorphism, immunodeficiency, livedo, short stature (FILS) syndrome Normal; defective TCR mediated activation AR AR Normal; defective TCR mediated activation AR Mutations in nuclear body protein encoded by SP110 604457 Mutation in ORAI1, a Ca++ release-activated channel (CRAC) modulatory component 610277 Mutations in STIM1, a stromal interaction molecule 1 605921 Hepatic veno-occlusive disease with immunodeficiency (VODI) 10. Other defects STIM1 deficiency ORAI-I deficiency 9. Calcium channel defects Normal total T cells;; impaired TCR activation AD EDA-ID IKBA gain of function mutation Gain of function mutation in IKBA (NFKIAB), encoding IκBα, a component of the NF-κB pathway Gain-of-function mutation of IKBA, resulting in impaired activation of NF-κB 164008 Normal or decreased; poor CR activation function Low Variable numbers and activation profile AR AR Normal Circulating T cells AR Inheritance XL Mutations in enzyme encoded by MTHFD, essential for processing single-carbon folate derivatives Mutation in TCN2; encoding a transporter of cobalamin into blood cells 613441 Mutation in SLC46A1, encoding a proton coupled folate transporter Mutation in PARN, POLYADENYLATESPECIFIC RIBONUCLEASE 604212 Genetic defect/Presumed pathogenesis OMIM number gene locus (EDA-ID. NEMO /IKBKG deficiency Mutations of NEMO (IKBKG), a modulator of NF-κB activation Defects in IKBKG, encoding NEMO, a component of the NF-κB pathway Mutations of NEMO (IKBKG), a modulator of NF-κB activation 300248 8. Anhidrotic ectodermaldysplasia with immunodeficiency (EDA-ID) Methylene-tetrahydrofolate dehydrogenase 1 (MTHFD1) deficiency SLC46A1/PCFT deficiency causing hereditary folate malabsorbtion Transcobalamin 2 (TCN2) deficiency 7. Defects of Vitamin B12 and Folate metabolism AR-DKC due to PARN deficiency Disease Table 2 (continued) Low memory B cells Normal (decreased memory B cells) Normal Decreased IgM and IgG; Lack of antibodies to polysaccharide antigens Decreased IgG, IgA, IgM; absent germinal centers and tissue plasma cells Normal Normal Decreased; poor specific antibody responses, absent antibody to polysaccharide antigens Normal B cell numbers; impaired BCR activation; Normal Decreased; poor specific antibody responses, absent antibody to polysaccharide antigens Decreased Decreased Decreased Serum Ig Normal Low B memory B cells Low Variable Variable Circulating B cells Hepatic veno-occlusive disease; Susceptibility to Pneumocystis jiroveci pneumonia, CMV, candida; thrombocytopenia; hepatosplenomegaly; cerebrospinal leukodystropy Mild facial dysmorphism (malar hypoplasia, high forehead), livedo, short stature; recurrent upper and lower respiratory tract infections, recurrent pulmonary infections and recurrent meningitis Autoimmunity, anhydrotic ectodermal dysplasia, non-progressive myopathy Autoimmunity, anhydrotic ectodermic dysplasia, non-progressive myopathy anhidrotic ectodermal dysplasia + specific antibody deficiency (lack of Ab response to polysaccharides) + various infections (mycobacteria and pyogens) Various infections (bacteria, mycobacteria, viruses and fungi); colitis, EDA (not in all patients); conical teeth, variable defects of skin pigmentation, monocyte dysfunction Various infections (bacteria, mycobacteria, viruses and fungi); colitis, EDA (not in all patients); variable defects of skin, hair and teeth, T cell and monocyte dysfunction Anhidrotic ectodermal dysplasia + T cell defect + various infections: Recurrent bacterial, viral and fungal infections; Megaloblastic anaemia, pancytopaenia, if untreated for prolonged periods results in mental retardation Megaloblastic anaemia, failure to thrive, if untreated f or prolonged periods results in mental retardation Megaloblastic anaemia, failure to thrive, neutropenia, s eizures, mental retardation Associated features 615139 235550 612783 612782 612132 300291, 300584, 300301 300640 601634 172460 229050 611672 275350 OMIM number Phenotype J Clin Immunol (2015) 35:696–726 707 Mutation in TTC7A (tetratricopeptide repeat (TPR) domain 7A) protein, of unkown function 609332 Mutations in EPG5 encoding ectopic P-granules autophagy protein 5, involved in the formation of autolysosomes required for autophagy Mutation of PNP leading to absent PNP, T cell and neurologic defects from elevated toxic metabolites, especially dGTP 164050 Mutation of HOIL1/RBCK1, encoding a component of the linear ubiquitination chain assembly complex LUBAC, resulting in impaired activation of NF-κB 610924 Mutation of HOIP1 (/RNF31), encoding a component of the linear ubiquitination chain assembly complex LUBAC, resulting in impaired activation of NF-κB 612487 Mutation of CCBE1: (COLLAGEN AND CALCIUM-BINDING EGF DOMAINCONTAINING PROTEIN1) 612753 Mutations in STAT5B signal transducer and transcription factor, essential for normal signaling from IL-2 and 15, key growth factors for T and NK cells, as well as other cytokines 604260 Genetic defect/Presumed pathogenesis OMIM number gene locus Low/variable Modestly decreased AR Normal numbers AR AR Normal numbers, AR Profound depletion of CD4+ cells AR Progressive decrease Variable, but sometimes absent AR AR Circulating T cells Inheritance Normal Low/variable Normal, but decreased memory B cells Normal, but decreased memory B cells Normal Defective Normal Circulating B cells Normal decreased decreased Poor antibody production to polysaccharide antigens Normal or decreased Decreased (particularly IgG2) Decreased Serum Ig Growth-hormone insensitive dwarfism, dysmorphic features, eczema, lymphocytic interstitial pneumonitis, autoimmunity Lymphangiactasia and lymphedema with facial abnormalities and other dysmorphic features Bacterial infections (pyogens), autoinflammation. Amylopectinosis, Lymphangiectasia Bacterial infections (pyogens), autoinflammation. amylopectinosis Multiple intestinal atresias, often with intrauterine polyhydramnios and early demise; some with SCID phenotype Agenesis of the corpus callosum, cataracts, cardiomyopathy, skin hypopigmentation, cleft lip/palate, recurrent infections, chronic mucocutaneous candidiasis Autoimmune haemolytic anemia, neurological impairment Associated features 245590 235510 Not yet assigned 615895 613179 242840 615068 243150 OMIM number Phenotype * Although TBX1 deletions are emphasized, data are lacking that demonstrate that isolated TBX1 haploinsufficiency (affecting solely the gene and none of the surrounding 22q11.2 region) explicitly causes T cell or immunologic deficiency in humans Notes: T and B cell number and function in these disorders exhibit a wide range of abnormality; the most severely affected cases meet diagnostic criteria for SCID or leaky SCID and require immune system restoring therapy such as allogeneic hematopoietic cell transplantation New genes added: TPP1, DCLRE1B, PARN, CCBE1, HOIP1, EPG5 Total no. of genes in Table 2: 45 STAT5b deficiency Hennekam-lymphangiectasialymphedema syndrome HOIP deficiency HOIL1 deficiency Purine nucleoside phosphorylase (PNP) deficiency Vici syndrome due to EPG5 deficiency Immunodeficiency with multiple intestinal atresias Disease Table 2 (continued) 708 J Clin Immunol (2015) 35:696–726 Genetic defect/Presumed pathogenesis Gene OMIM Genetic defect/Presumed pathogenesis Disease Mutations in CD19; transmembrane protein that amplifies signal through BCR 107265 Mutations in CD81; transmembrane protein that amplifies signal through BCR 186845 Mutations in CD20; a B cell surface receptor involved in B cell development and plasma cell differentiation 112210 Mutations in CD21; also known as complement receptor 2 and forms part of the CD19 complex 120650 Mutations in TNFRSF13B (TACI); a TNF receptor family member found on B cells and is a receptor for BAFF and APRIL 604907 Mutations in TNFRSF13C (BAFF-R); a TNF receptor family member found on B cells and is a receptor for BAFF 606269 Mutations in a cytokine TWEAK (TNFSF12); TNF-related weak inducer of apoptosis 602695 Mutations in NFKB2; an essential component of the noncanonical NF-κB pathway Mutation in mannosyl-oligosaccharide glucosidase 601336 CD19 deficiency MOGS deficiency NFKB2 deficiency TWEAK deficiency BAFF receptor deficiency TACI deficiency CD21 deficiency CD20 deficiency CD81 deficiency Unknown Common variable immunodeficiency disorders 2. Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells E47 transcription factor deficiency PI3KR1 deficiency BLNK deficiency Thymoma with immunodeficiency Mutations in BTK, a cytoplasmic tyrosine kinase activated by crosslinking of the BCR 300300 Mutations in μ heavy chain (IGHM); essential component of the pre-BCR 147020 Mutations in λ5 (IGLL1); part of the surrogate light chain in the pre-BCR 146770 Mutations in Igα (CD79A); part of the pre-BCR and BCR 112205 Mutations in Igb (CD79B); part of the pre-BCR and BCR 147245 Mutations in BLNK; a scaffold protein that binds to BTK 604615 Mutations in PIK3R1; a kinase involved in signal transduction in multiple cell types. Complete loss of PI3K p85-alpha resulting in complete loss of B cell development 171833 Mutations in TCF3; a transcription factor required for control of B cell development 147141 Unknown Igβ deficiency Igα deficiency λ5 deficiency μ heavy chain deficiency BTK deficiency 1. Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells Disease Table 3 Predominantly antibody deficiencies AR AD AD AR Low IgG and IgA and IgM; very low B cells in some Severe hypogammaglobulinemia; Low IgM and A; lack of antipneumococcal antibody Low IgG and IgM; Low IgG and IgA and/or IgM Low IgG; impaired anti-pneumococcal response AR AD or AR or complex Low IgG, normal or elevated IgM and IgA Low IgG, low or normal IgA and IgM Low IgG and IgA and/or IgM AR AR AR Low IgG and IgA and/or IgM Serum Ig Inheritance Variable One or more isotypes may be decreased None All isotypes decreased AD All isotypes decreased AR All isotypes decreased All isotypes decreased AR AR All isotypes decreased All isotypes decreased All isotypes decreased in majority of patients; some patients have detectable immunoglobulins All isotypes decreased Serum Ig AR AR AR XL Inheritance Recurrent infections; adrenal insufficiency; ACTH deficiency; alopecia Bacterial and viral infections; severe neurologic disease; also contains glycosylation type IIb (CDG-IIb), Pneumonia, bacterial infections, warts; thrombocytopenia. neutropenia Variable clinical expression Variable clinical expression Recurrent infections Recurrent infections Recurrent infections; May have glomerulonephritis Clinical phenotypes vary: most have recurrent infections, some have polyclonal lymphoproliferation, autoimmune cytopenias and/or granulomatous disease Recurrent infections; May have glomerulonephritis Bacterial and opportunistic infections; autoimmunity; decreased number of pro-B cells Associated features Recurrent bacterial infections Severe bacterial infections; normal numbers of pro-B cells Severe bacterial infections; decreased or absent pro-B cells Severe bacterial infections; normal numbers of pro-B cells Severe bacterial infections; normal numbers of pro-B cells Severe bacterial infections; normal numbers of pro-B cells Severe bacterial infections; normal numbers of pro-B cells Severe bacterial infections; normal numbers of pro-B cells Associated features 606056 615577 not yet assigned 613494 240500 614699 613495 613496 613493 OMIM number Not yet assigned 615214 613502 612692 112205 613501 613500 601495 300755 Phenotype OMIM number J Clin Immunol (2015) 35:696–726 709 Mutation in TRNT1 a templateindependent RNA polymerase required for the maturation of cytosolic and mitochondrial transfer RNAs (tRNAs) 612907 Mutation in TTC37 gene 614589 AR AR Variable Variable Unknown Unknown IgA with IgG subclass deficiency Specific antibody deficiency with normal Ig concentrations and normal numbers of B cells Variable AR Unknown Mutations in Kappa constant gene Isolated IgG subclass deficiency IGKC deficiency 4. Isotype or light chain deficiencies with generally normal numbers of B cells Activated PI3K-δ Mutation in PIK3CD; p110 AD gain of encoding for p110 subunit of PI3K function 602839 AD loss of PI3KR1 loss of function Mutation in PIK3R1 leading to function mutations in p85α of p85α (leading 171833 to activation of PI3K-δ – as above) Ig heavy chain mutations Mutation or chromosomal deletion at AR and deletions 14q32 3. Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells AID deficiency Mutations in AICDA gene AR 605257 UNG deficiency Mutations in UNG AR 191525 AR INO80 INO80 chromatin remodeling complex; mild DNA repair defect 610169 AR MSH6 MSH6 gene defect part of mismatch repair [MMR] machinery); DNA repair defect 600678 TTC37 deficiency TRNT1 deficiency Table 3 (continued) Reduced IgA with decrease in one or more IgG subclass Normal May be asymptomatic One or more IgG and/or IgA subclasses as well as IgE may be absent All immunoglobulins have lambda light chain Reduction in one or more IgG subclass Reduced ability to produce antibodies to specific antigens Usually asymptomatic; a minority may have poor antibody response to specific antigens and recurrent viral/bacterial infections Recurrent bacterial infections Asymptomatic Respiratory infections, bronchiectasis; autoimmunity; chronic EBV, CMV infection EBV, CMV viremia; growth retardation Family or personal history of cancer Variable IgG, defects; increased IgM in some; normal B cells, low switched memory B cells; Ig-CSR and SHM defects Reduced IgG2 and impaired antibody to pneumococci and hemophilus Absent IgA, low IgG Bacterial infections; enlarged lymph nodes and germinal centers Enlarged lymph nodes and germinal centers Severe bacterial infections Recurrent bacterial and viral infections; Abnormal hair findings: trichorrhexis nodosa congenital sideroblastic anemia; deafness; developmental delay IgG and IgA decreased; IgM increased IgG and IgA decreased; IgM increased IgG and IgA decreased; IgM increased Poor antibody response to pneumococcal vaccine B cell deficiency and hypogammaglobulinemia 147200 616005 615513 not yet assigned not yet assigned 608106 605258 222470 616084 710 J Clin Immunol (2015) 35:696–726 Variable AD Unknown CARD11; scaffold for NF-kB activity in the adaptive immune response; gain of function Congenital B cell lymphocytosis. High B cell numbers due to constitutive NF-κB activation IgG and IgA decreased Normal ability to produce antibodies to vaccine antigens, usually not associated with significant infections Splenomegaly; lymphadenopathy 607210; 606445 AID activation-induced cytidine deaminase, UNG uracil-DNA glycosylase, Ig(κ) immunoglobulin or κ light-chain type XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance; BTK Bruton tyrosine kinase, BLNK B cell linker protein Common Variable Immunodeficiency Disorders (CVID) include several clinical and laboratory phenotypes that may be caused by distinct genetic and/or environmental factors. Some patients with CVID and no known genetic defect have markedly reduced numbers of B cells as well as hypogammaglobulinemia. Alterations in TNFRSF13B (TACI) and TNFRSF13C (BAFF-R) sequences may represent disease modifying mutations rather than disease causing mutations. A small minority of patients with XLP (Table 4), WHIM syndrome (Table 6), ICF (Table 2), VOD1 (Table 2), thymoma with immunodeficiency (Good syndrome) or myelodysplasia are first seen by an immunologist because of recurrent infections, hypogammaglobulinemia and normal or reduced numbers of B cells Notes: Several autosomal recessive disorders that might previously have been called CVID have been added to Table 3. CD81 is normally co-expressed with CD19 on the surface of B cells. As for CD19 mutations, mutations in CD81 result in normal numbers of peripheral blood B cells, low serum IgG and an increased incidence of glomerulonephritis New genes added: MOGS, TRNT1, TTC37, IN08, MSH6, PI3KR1 AD Total no. of gene in Table 3: 28 Transient hypogammaglobulinemia of infancy with normal numbers of B cells CARD 11 gain of function Table 3 (continued) J Clin Immunol (2015) 35:696–726 711 Genetic defect/Presumed pathogenesis Gene OMIM Mutations in PRF1; perforin is a major cytolytic protein 170280 Mutations in UNC13D; required to prime vesicles for fusion 608897 Mutations in IL2RA, encoding IL-2Rα chain, 147730 Mutations in CTLA4, encoding Cytotoxic T Lymphocyte antigen 4, a protein that CD25 deficiency CTLA4 deficiency (ALPSV) Mutations in FOXP3, encoding a T cell transcription factor 300292 IPEX, immune dysregulation, polyendocrinopathy, enteropathy X-linked 2. T regulatory cells genetic defects Hermansky-Pudlak syndrome, type 9 Hermansky-Pudlak syndrome, type 2 AD AR XL Mutations in RAB27A encoding AR a GTPase that promotes docking of secretory vesicles to the cell membrane 603868 AR Mutations in AP3B1 gene, encoding for the β subunit of the AP-3 complex 603401 Mutations in PLDN, encoding AR Pallidin, a component of the biogenesis of lysosome-related organelles complex-1 (BLOC1) 604310 Griscelli syndrome, type2 Normal or Increased activated T cells; low/normal iNK T cells XL Decreased Normal to decreased Normal Decreased Normal Normal (Not assessed, leukopenia) Normal Normal (Not assessed; leukopenia) Normal Normal Normal or reduced Memory B cells Fever, HSMG, HLH, Cytopenias, Fever, HSMG, HLH, Cytopenias, Fever, Hepato-Splenomegaly (HSMG), Hemophagocytic lymphohistiocytosis (HLH), Cytopenias Fever, HSMG, HLH, Cytopenias, Associated Features No CD4 + C25+ cells with impaired f unction of Tregs cells Impaired function of Treg cells. Lack of (and/or impaired function of) CD4+ CD25+ FOXP3+ regulatory T cells (Tregs) Decreased NK cell cytolytic activity Decreased NK and CTL activities (cytotoxicity and/or degranulation) Decreased NK and CTL activities (cytotoxicity and/or degranulation) Decreased NK and CTL activities (cytotoxicity and/or degranulation) Autoimmune enteropathy, early onset diabetes, thyroiditis hemolytic anemia, thrombocytopenia, eczema Elevated IgE, IgA Lymphoproliferation, autoimmunity. Impaired T cell proliferation Autoimmune cytopenias, enteropathy, interstitial lung disease, Oculocutaneous albinism, recurrent cutaneous infections, leukopenia, thrombocytopenia Partial albinism, recurrent infections, pulmonary fibrosis Increased bleeding, neutropenia, HLH Partial albinism, recurrent infections, fever, HSMG, HLH Giant lysosomes, neutropenia, cytopenias, bleeding tendency, progressive neurological dysfunction Partial albinism, fever, HSMG, HLH, cytopenias Clinical and immunologic features triggered by EBV infection: HLH, lymphoproliferation, Aplastic anaemia, lymphoma. Hypogammaglobulinemia, absent iNKT cells Increased T cells susceptibility to apoptosis EBV infection, Splenomegaly, lymphoproliferation to CD95 and enhanced activationHLH, Colitis, IBD, hepatitis induced cell death (AICD) Low iNKT cells Decreased NK and CTL activities (cytotoxicity and/or degranulation) Decreased to absent NK and CTL activities (cytotoxicity and/or degranulation) Decreased NK activity (cytotoxicity and/or degranulation) Decreased to absent NK and CTL activities cytotoxicity Reduced Memory partially defective NK cell and CTL B cells cytotoxic activity Normal Normal Normal Normal Circulating B Functional defect cells Normal Increased activated T cells Normal or increased activated T cells XL AR Increased activated T cells AR or AD Mutations in LYST, impaired lysosomal trafficking 606897 Increased activated T cells Increased activated T cells Increased activated T cells AR AR AR Inheritance Circulating T Cells Chediak-Higashi syndrome Mutations in STX11, required for secretory vesicle fusion with the cell membrane 605014 STXBP2 / Munc18-2 deficiency Mutations in STXBP2, required (FHL5) for secretory vesicle fusion with the cell membrane 601717 SH2D1A deficiency (XLP1) Mutations in SH2D1A encoding an adaptor protein regulating intracellular signaling 300490 XIAP deficiency (XLP2) Mutations in XIAP/ BIRC4 encoding an inhibitor of apoptosis 300079 1.2. FHL syndromes with hypopigmentation Syntaxin 11 deficiency, (FHL4) (UNC13D / Munc13-4 deficiency (FHL3) Perforin deficiency (FHL2) 1.1. FHL syndromes without hypopigmentation 1. Familial hemophagocytic lymphohistiocytosis (FHL) syndromes Disease Table 4 Diseases of immune dysregulation 616100 606367 304790 614171 608233 607624 214500 300635 308240 613101 603552 608898 603553 Phenotype OMIM number 712 J Clin Immunol (2015) 35:696–726 Increased DN T cells AR PRKC delta deficiency FADD deficiency ALPS-Caspase 8 ALPS-Caspase10 ALPS-FASLG Germinal mutations in TNFRSF6, encoding CD95/Fas cell surface apoptosis receptor** 134637 Mutations in TNFSF6, Fas ligand for CD95 apoptosis 134638 Mutations in CASP10, intracellular apoptosis pathway 601762 Mutations in CASP8, intracellular apoptosis and activation pathways 601763 Mutations in FADD encoding an adaptor molecule interacting with FAS, and promoting apoptosis 602457 Mutations in PRKCD, encoding a member of the protein kinase C family critical for regulation AR AR AR Normal Increased DN T cells Slightly increased DN T cells Increased DN T cells Normal, low memory B cells Increased CD4−CD8−TCRαβ double negative (DN) T cells AD AR*** ALPS-FAS AD Decreased Decreased AR Low memory B cells and Elevation of CD5 B cells Normal Normal Normal Normal Not assessed Not assessed AR ITCH deficiency Mutations in ITCH, an E3 ubiquitin ligase catalyzes the transfer of ubiquitin to a signaling proteins in the cell including phospholipase Cγ1 (PLCγ1) 606409 Tripeptidyl-Peptidase II Deficiency Mutations in TPP2, encoding tripeptidylpeptidase II, serine exopeptidase involved in extralysosomal peptide degradation 190470 3. Autoimmune lymphoproliferative syndrome (ALPS) AR Normal Decreased extra-lymphoid lymphocytic infiltration recurrent infections, Associated Features Apoptotic defect in B cells Defective lymphocyte apoptosis Defective lymphocyte apoptosis and activation Defective lymphocyte apoptosis Apoptosis defect FAS mediated Apoptosis defect FAS mediated TPP2 deficiency results in premature immunosenescence and immune dysregulation Itch deficiency may cause immune dysregulation by affecting both anergy induction in auto-reactive effector T cells and generation of Tregs AIRE-1 serves as check-point in the thymus for negative selection of autoreactive T cells and for generation of Tregs 615952 Phenotype OMIM number Recurrent infections; EBV chronic infection Lymphoproliferation SLE-like autoimmunity (Nephrotic and antiphospholipid syndromes) Functional hyposplenism, Bacterial and viral infections, Recurrent episodes of encephalopathy and liver dysfunction. Adenopathies, splenomegaly, Bacterial and viral infections, Hypogammaglobulinemia Splenomegaly, adenopathies, autoimmune cytopenias, SLE; Soluble FasL is not elevated Adenopathies, splenomegaly, autoimmunity. Splenomegaly, adenopathies, Autoimmune cytopenias, increased lymphoma risk. IgG and A normal or increased Elevated FasL and IL-10, vitamin B12 Variable lymphoproliferation, severe autoimmune cytopenias, hypergammaglobulinemia, recurrent infections, 615559 613759 607271 603909 601859 601859 Not yet assigned Autoimmunity: hypoparathyroidism hypothyroidism, 240300 adrenal insufficiency, diabetes, gonadal dysfunction and other endocrine abnormalities, chronic mucocutaneous candidiasis, dental enamel hypoplasia, alopecia areata Enteropathy, Pernicious anemia, Early-onset chronic lung disease (interstitial 613385 pneumonitis) Autoimmune disorder (thyroiditis, type I diabetes, chronic diarrhea/enteropathy, and hepatitis) Failure to thrive, developmental delay, dysmorphic facial features Enhanced STAT3 signaling, leading to Lymphoproliferation, Solid organ autoimmunity, increased Th17 cell differentiation, recurrent infections. lymphoproliferation and autoimmunity. Decreased Treg cell numbers and impaired phenotype Circulating B Functional defect cells APECED (APS-1), autoimmune Mutations in AIRE, encoding a polyendocrinopathy transcription regulator needed with candidiasis and ectodermal to establish thymic selfdystrophy tolerance 607358 Normal Decreased Inheritance Circulating T Cells negatively regulate T cell receptor signaling and T cell activation. 123890 Mutations in STAT3, encoding AD Signal Transducer and activator 3 102582 Genetic defect/Presumed pathogenesis Gene OMIM 3. Autoimmunity with or without lymphoproliferation STAT3 GOF mutations Disease Table 4 (continued) J Clin Immunol (2015) 35:696–726 713 Mutations in RNASEH2B, encoding nuclease subunit involves in clearing cellular nucleic debris 610326 Mutations in RNASEH2C, encoding nuclease subunit involves in clearing cellular nucleic debris 610330 Mutations in RNASEH2A, encoding nuclease subunit involves in clearing cellular nucleic debris 606034 Mutations in SAMHD1, encoding negative regulator of the immunostimulatory DNA response 606754 Mutations in ADAR1, encoding a RNA-specific adenosine deaminase 146920 IFIH1 606951 RNASEH2B deficiency, AGS2 Spondyloenchondro-dysplasia with Mutations in ACP5, encoding tartrate-resitant acid immune phosphatase dysregulation (SPENCD) (TRAP) 171640 Aicardi-Goutieres syndrome 7 (AGS7) ADAR1 deficiency, AGS6 SAMHD1 deficiency, AGS5 RNASEH2A deficienc y, AGS4 RNASEH2C deficiency, AGS3 syndrome 1 (AGS1) Mutations in TREX1, encoding nuclease involves in clearing cellular nucleic debris 606609 Mutations in IL10, encoding IL-10 124092 Mutations in IL10RA, encoding IL-10R1 146933 Mutations in IL10RB, encoding IL-10R2 123889 Hemizygous deletion of NFAT5 604708 of cell survival, proliferation and apoptosis 176977 Genetic defect/Presumed pathogenesis Gene OMIM TREX1 deficiency, AicardiGoutieres 5. Type 1 Interferonopathies NFAT5 haploinsufficiency IL-10Rβ deficiency IL-10Rα deficiency IL-10 deficiency 4. Immune dysregulation with colitis Disease Table 4 (continued) AR AD AR AR AR AR AR AR AD***** AD Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Normal Normal Normal AR AR Normal AR Inheritance Circulating T Cells Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Normal Normal Normal Normal Inflammatory bowel disease (IBD) Folliculitis, Recurrent respiratory diseases, Arthritis, IBD, Folliculitis, Recurrent respiratory diseases, Arthritis, Lymphoma IBD, Folliculitis, Recurrent respiratory diseases, Arthritis, Lymphoma IBD, recurrent sinopulmonary infections HypoIgG Associated Features IFIH1 gene encodes a cytoplasmic viral RNA receptor that activates type I interferon signaling through the MAVS adaptor molecule Upregulation of IFN-alpha and type I IFNstimulated genes Recurrent bacterial and viral infections, Intracranial calcification, SLE-like autoimmunity (Sjögren’s syndrome, hypothyroidism, inflammatory myositis, Raynaud’s disease and vitiligo), hemolytic anemia, thrombocytopenia, Progressive encephalopathy intracranial calcification, Severe developmental delay, leukodystrophy Progressive encephalopathy Intracranial calcifications, Cerebral atrophy, leukodystrophy, HSMG, Thrombocytopenia, Elevated hepatic transaminases Chronic cerebrospinal fluid (CSF) lymphocytosis Intracellular accumulation of abnormal Progressive encephalopathy Intracranial calcifications, ss-DNA species leading to increased Cerebral atrophy, leukodystrophy, CSF alpha-IFN production HSMG, thrombocytopenia, Elevated hepatic transaminases Chronic CSF lymphocytosis Intracellular accumulation of abnormal Progressive encephalopathy Intracranial calcifications, ss-DNA species leading to increased Cerebral atrophy, leukodystrophy, CSF alpha-IFN production HSMG, thrombocytopenia, Elevated hepatic transaminases Chronic CSF lymphocytosis Intracellular accumulation of abnormal Progressive encephalopathy Intracranial calcifications, ss-DNA species leading to increased Cerebral atrophy, leukodystrophy, CSF alpha-IFN production HSMG, thrombocytopenia, Elevated hepatic transaminases Chronic CSF lymphocytosis Induction of the cell intrinsic antiviral Progressive encephalopathy Intracranial calcifications, response, apoptosis, and Cerebral atrophy, leukodystrophy, mitochondrial DNA destruction HSMG, thrombocytopenia, anemia elevated lactates Chronic CSF lymphocytosis, leading to increased CSF alpha-IFN Skin vascularitis, mouth ulcers, arthropathy production Catalyzes the deamination of adenosine to Progressive encephalopathy intracranial calcification, inosine in dsRNA substrates Markedly Severe developmental delay, leukodystrophy elevated CSF IFN-alpha Intracellular accumulation of abnormal single-stranded (ss) DNA species leading to increased CSF alpha-IFN production Leukocytes no response to IL-10, IL-22, IL-26, IL-28A, IL-28B, and IL-29 Decreased memory B cells and plasmablasts Leukocytes no response to IL-10 No functional IL-10 secretion Circulating B Functional defect cells 607944 615846 615010 612952 610333 610329 610181 225750 Not yet assigned 612567 613148 not assigned Phenotype OMIM number 714 J Clin Immunol (2015) 35:696–726 Inheritance Circulating T Cells Not assessed Not assessed AR AR Genetic defect/Presumed pathogenesis Gene OMIM TMEM173 encoding for STIMULATOR OF INTERFERON GENES 612374 Mutations in CECR1; encoding ADA2 607575 Not assessed Not assessed Associated Features skeletal dysplasia, short stature STING activates both the NF-kappa-B and Severe infantile-onset autoinfammatory vasculopathy, IRF3 transcription pathways to induce expression of IFN-alpha and IFN-beta and exert a potent antiviral effect Polyarteritis nodosa, childhood-onset, early-onset ADAs deactivate extracellular adenosine recurrent ischemic stroke and fever and terminate signaling through adenosine receptors Circulating B Functional defect cells 615688 615934 Phenotype OMIM number ***** de novo dominant TREX1 mutations have been reported **** Somatic mutations in KRAS or NRAS can give this clinical phenotype associated auto-immune leukoproliferative disease (RALD) and are now include in Table 9 entitled Phenocopies of PID *** AR ALPS-FAS patients have a most severe clinical phenotype ** Somatic mutations of TNFRSF6 cause a similar phenotype (ALPS-sFAS) see Table 9. Germinal mutation and somatic mutations of TNFRSF6 can be associated in some ALPS-FAS patients XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, FHL familial hemophagocytic lymphohistiocytosis, HLH Hemophagocytic lymphohistiocytosis, HSMG hepato-splenomegaly, DN double-negative, SLE systemic lupus erythematous, IBD inflammatory bowel disease, CSF chronic cerebrospinal fluid New genes added: PLDN, CTLA4, TPP2, NFAT5, IFIH1, TMEM173, CECR1, STAT 3 (GOF) Total no. of genes in Table 4: 37 ADA2 deficiency STING–associated vasculopathy, infantileonset Disease Table 4 (continued) J Clin Immunol (2015) 35:696–726 715 Leukocyte adhesion deficiency type 1 (LAD1) 2. Defects of Motility Disease G-CSF receptor deficiency 3-Methylglutaconic aciduria Clericuzio syndrome Poikiloderma with neutropenia JAGN1 deficiency Cohen syndrome Barth Syndrome P14/LAMTOR2 deficiency X-linked neutropenia/ myelodysplasia Cyclic neutropenia Glycogen storage disease type 1b VPS45 deficiency (SCN5) Mutation in ITGB2: B chain for adhesion proteins CD18/CD11 600065 Mutations in CSF3R, the growth factor receptor 138971 Genetic defect/ Presumed pathogenesis Mutation in Tafazzin (TAZ) gene: Abnormal lipid structure of mitochondrial membrane, defective carnitine metabolism 300394 Mutation in COH1 gene: Pg unknown 607817 Mutation in C16ORF57 (USB1), affects genomic integrity 613276 Mutations in JAGN1, regulates secretory pathway 616012 Mutations in CLPB 616254 Mutation in G6PC3: abolished enzymatic activity of glucose-6-phosphatase, aberrant glycosylation, and enhanced apoptosis of N and F 611045 Mutation in VPS45 controls vesicular trafficking 610035 Mutation in G6PT1: Glucose-6phosphate transporter 1 602671 Mutation in ELANE: misfolded protein response 130130 Mutation in WAS: Regulator of actin cytoskeleton (loss of autoinhibition) 300392 Mutation in ROBLD3/LAMTOR2: Endosomal adaptor protein 14 610389 G6PC3 deficiency (SCN4) Kostmann Disease (SCN3) GFI 1 deficiency (SCN2) Mutation in ELANE: misfolded protein response, increased apoptosis 130130 Mutation in GFI1: loss of repression of ELANE 600871 Mutation in HAX1: control of apoptosis 605998 Genetic defect/ Presumed pathogenesis OMIM gene Elastase deficiency (SCN1) 1) Congenital neutropenias Disease Table 5 Congenital defects of phagocyte number, function, or both AR Inheritance AR N+M + L+NK Affected cells N N N AR AR N N AR AR N N+L Mel AR XL N+M XL, gain of function N N+M AR AD N+F N+F AR AR N N AD AR N Affected cells AD Inheritance Adherence, Chemotaxis, Endocytosis, Affected function Myeloid differentiation Myeloid differentiation Myeloid differentiation Myeloid differentiation Myeloid differentiation Myeloid differentiation Endosome biogenesis Mitosis Myeloid differentiation, chemotaxis, O2− production Differentiation Myeloid differentiation, migration Myeloid differentiation, chemotaxis, O2− production Myeloid differentiation Myeloid differentiation Myeloid differentiation Affected function Delayed cord separation, skin ulcers Periodontitis Associated features Microcephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGR Poor response to GCSF Some with a bone phenotype Retinopathy, developmental delay, facial dysmorphisms Poikiloderma, MDS Neutropenia Hypogammaglobulinemia ↓CD8 cytotoxicity Partial albinism Growth failure Cardiomyopathy, myopathy, growth retardation Monocytopenia 116920 OMIM number 162830 Not yet assigned 616022 604173 216550 302060 610798 300299 162800 232220 Fasting hypoglycemia, lactic acidosis, hyperlipidemia, hepatomegaly Oscillations of other leukocytes and platelets 615285 612541 610738 613107 202700 Phenotype OMIM number Extramedullary hematopoiesis, bone marrow fibrosis, nephromegaly, Cognitive and neurological defects in patients with defects in both HAX1 isoforms, susceptibility to MDS/leukemia Structural heart defects, urogenital abnormalities, inner ear deafness, and venous angiectasias of trunks and limbs B/T lymphopenia Susceptibility to MDS/leukemia Associated features 716 J Clin Immunol (2015) 35:696–726 Mutation in CSF2RA 306250 Pulmonary alveolar proteinosis* New genes added: JAGN1, CLBP, CSF3R Total no. of genes in Table 5: 31 Mutations in GATA2: loss of stem cells 137295 Mutation in CYBB: Electron transport protein (gp91phox) 300481 Mutation in CYBA: Electron transport protein (p22phox) 608508 Mutation in NCF1: Adapter protein (p47phox) 608512 Mutation in NCF2: Activating protein (p67phox) 608515 Mutation in NCF4: Activating protein (p40 phox) 601488 Mutation in SLC35C1: GDP-Fucose transporter 605881 Mutation in KINDLIN3: Rap1-activation of β1-3 integrins 607901 Mutation in RAC2: Regulation of actin cytoskeleton 602049 Mutation in ACTB: Cytoplasmic Actin 102630 Mutation in FPR1: Formylated peptide receptor 136537 Mutation in CTSC: Cathepsin C activation of serine proteases 602365 Mutation in C/EBPE: myeloid transcription factor 189965 Mutation in SBDS: Defective ribosome synthesis607444 GATA2 deficiency (Mono MAC syndrome) 4. Other Defects Autosomal recessive CGD Autosomal recessive CGD Autosomal recessive CGD X-linked chronic granulomatous disease (CGD) Autosomal recessive CGD Shwachman-Diamond Syndrome 3. Defects of Respiratory Burst Specific granule deficiency Papillon-Lefèvre Syndrome Localized juvenile periodontitis β-actin deficiency Leukocyte adhesion deficiency type 2 (LAD2) Leukocyte adhesion deficiency type 3 (LAD3) Rac 2 deficiency Table 5 (continued) Biallelic mutations in pseudoautosomal gene AD Alveolar macrophages Monocytes+peripheral DC; low NK cells N+M AR N+M AR N+M N+M AR AR N+M N N XL AR AR N+M N+M AD AR N AD N N+M + L+NK AR AR N+M AR Infections, autoinflammatory phenotype Infections, autoinflammatory phenotype Infections, autoinflammatory phenotype Killing (faulty O2 − production) Killing (faulty O2 − production) Killing (faulty O2 − production) GM-CSF signaling Multi lineage cytopenias Susceptibility to Mycobacteria, papilloma viruses, histoplasmosis, alveolar proteinosis, MDS/AML/CMML Alveolar proteinosis McLeod phenotype in patients with deletions extending into the contiguous Kell locus Infections, autoinflammatory phenotype Killing (faulty O2 − production) Killing (faulty O2 − production) Pancytopenia, exocrine pancreatic insufficiency, chondrodysplasia Neutrophils with bilobed nuclei Periodontitis, palmoplantar hyperkeratosis in some patients Periodontitis only 300770 614286 614172 613960 233710 233700 233690 306400 260400 245480 245000 Not assigned 243310 608203 Poor wound healing, leukocytosis Mental retardation, short stature 612840 266265 Leukocytosis Mild LAD type 1 features plus hh-blood group plus mental and growth retardation LAD type 1 plus bleeding tendency Chemotaxis Chemotaxis Chemotaxis Formylpeptide induced chemotaxis Adherence, chemotaxis O2 − production Motility Adherence, chemotaxis T/NK cytotoxicity Rolling, chemotaxis J Clin Immunol (2015) 35:696–726 717 Genetic defect/Presumed pathogenesis OMIM gene 2. Epidermodysplasia verruciformis EVER1 deficiency RORc deficiency ISG15 deficiency Tyk2 deficiency IRF8-deficiency (AD form) Macrophage gp91 phox deficiency STAT1 deficiency (AD form) IFN-γ receptor 2 deficiency IFN-γ receptor 1 deficiency IFN-γ receptor 1 deficiency IL-12p40 deficiency IL-12 and IL-23 receptor β1 chain deficiency Mutations of TMC6 605828 Mutation in ISG15 147571 Mutation in RORC 602943 Mutation in IL12RB1: IL-12 and IL-23 receptor β1 chain 601604 Mutation in IL12B : subunit p40 of IL12/IL23 161561 Mutation in IFNGR1: IFN-γR ligand binding chain 107470 Mutation in IFNGR1: IFN-γR ligand binding chain 107470 Mutation in IFNGR2: IFN-γR accessory chain 147569 Mutation in STAT1 (lost of function) 600555 Mutation in CYBB: Electron transport protein (gp 91 phox) 300481 Mutation in IRF8: IL12 production by CD1c+ MDC 601565 Mutation in TYK2 176941 1. Medelian Susceptibility to mycobacterial disease (MSMD) Disease Table 6 Defects in Intrinsic and Innate Immunity AR AR AR AR AD XL AD AR AD AR AR AR Inheritance Keratinocytes and leukocytes L+NK Normal, but Multiple cytokine signaling defect CD1c+MDC Mϕ only M+L M+L M+L M+L M L+NK Affected Cell EVER proteins may be involved in the regulation of cellular zinc homeostasis in lymphocytes lack of functional RORγT protein : IFNγ defect production complete absence of IL-17A/F-producing T cells IFNγ defect production Normal Differentiation of CD1c+MDC subgroup Killing (faulty O2 − production) IFN-γsignaling IFN-γ signaling IFN-γ binding and signaling IFN-γ binding and signaling IFN-γ secretion IFN-γ secretion Functional Defect HPV (group B1) infections and cancer of the skin (typical EV) Susceptibility to intracellular bacteria (Mycobacteria, Salmonella), fungi and viruses (+/−) Elevated IgE Susceptibility to Mycobacteria (BCG) Brain calcification mycobacteriosis and candidiasis Susceptibility to Mycobacteria 226400 Not yet assigned 616126 611521 614893 300645 614892 Susceptibility to Mycobacteria, Salmonella Isolated susceptibility to mycobacteria 614889 615978 209950 614890 614891 Phenotype OMIM Number Susceptibility to Mycobacteria and Salmonella Susceptibility to Mycobacteria and Salmonella Susceptibility to Mycobacteria and Salmonella Susceptibility to Mycobacteria and Salmonella Susceptibility to Mycobacteria and Salmonella Associated Features 718 J Clin Immunol (2015) 35:696–726 IL-17F deficiency IL-17RC deficiency IL-17RA deficiency 7. Chronic mucocutaneous candidiasis (CMC) CARD9 deficiency 6. Predisposition to invasive fungal diseases TBK1 deficiency TRIF deficiency TRAF3 deficiency UNC93B1 deficiency (a) Mutations in IL17RA 605461 Mutations in IL17RC 610925 (b) Mutations in IL17F Mutations of CARD9 607212 (b) Mutations of TLR3 603029 (a) Mutations of UNC93B1 608204 (c) Mutations of TRAF3 601896 (c) Mutations of TRIF, also called TICAM1 607601 (c) Mutations of TBK1 604834 Mutation in CD16 146740 CD16 deficiency 5. Herpes simplex encephalitis (HSE) TLR3 deficiency Mutation in IRF7 605047 IRF7 deficiency STAT2 deficiency Mutations of STAT1 600555 Mutations of STAT2 600556 Gain-of-function mutations of CXCR4, the receptor for CXCL12 162643 WHIM (Warts, Hypogammaglobulinemia, infections, Myelokathexis) syndrome 4. Predisposition to severe viral infection STAT1 deficiency Mutations of TMC8 605829 Genetic defect/Presumed pathogenesis OMIM gene EVER2 deficiency Disease Table 6 (continued) AD AR AR AR AD AD AR AD AR AD AR AR AR AR AR AD AR Inheritance Epithelial cells, fibroblasts, mononuclear phagocytes Epithelial cells, fibroblasts, mononuclear phagocytes T cells Mononuclear phagocytes CNS resident cells and fibroblasts CNS resident cells and fibroblasts CNS resident cells and fibroblasts Central nervous system (CNS) resident cells and fibroblasts CNS resident cells and fibroblasts Leukocytes and plasmacytoid dendritic cells, Non-hematopoietic cells NK cells T and NK cells and monocytes T and NK cells Granulocytes + Lymphocytes Keratinocytes and leukocytes Affected Cell IL-17 F-containing dimers IL-17RC signaling pathway IL-17RA signaling pathway CARD9 signaling pathway TBK1-dependent IFN-α, -β, and -λ induction TRIF-dependent IFN-α, -β, and -λ induction TRAF3-dependent IFN-α, -β, and -λ induction UNC-93B-dependent IFN-α, -β, and -λ induction TLR3-dependent IFN-α, -β, and -λ induction Deficient spontaneous NK cell cytotoxicity IFN-α, and -β production IFN-λ production STAT1-dependent IFN-α, and -β response STAT2-dependent IFN-α, and -β response EVER proteins may be involved in the regulation of cellular zinc homeostasis in lymphocytes Increased response of the CXCR4 chemokine receptor to its ligand CXCL12 (SDF-1) Functional Defect CMC Folliculitis CMC Folliculitis CMC Invasive candidiasis infection Deep dermatophytoses Herpes simplex virus 1 encephalitis Herpes simplex virus 1 encephalitis Herpes simplex virus 1 encephalitis Herpes simplex virus 1 encephalitis (incomplete clinical penetrance for all etiologies listed here) Herpes simplex virus 1 encephalitis Susceptibility to severe viral infections, inc. HSV, EBV, HPV Severe viral infections Mycobacterial infection Severe viral infections (disseminated vaccinestrain measles) Severe influenza disease warts/Human Papilloma virus (HPV) infection Neutropenia Reduced B cell number Hypogammaglobulinemia HPV (group B1) infections and cancer of the skin (typical EV) Associated Features 613956 Not yet assigned 613953 212050 Not yet assigned 614850 614849 610551 613002 615707 Not yet assigned Not yet assigned 613796 193670 226400 Phenotype OMIM Number J Clin Immunol (2015) 35:696–726 719 Mutations in APOL- I 603743 Mutations of IRAK4, a component of TLRand IL-1R-signaling pathway 606883 Mutations of MYD88, a component of the TLR and IL-1R signaling pathway 602170 Mutations in RPSA 150370 (c) Mutations in ACT1, also called TRAF3IP2 (607043) 606496 (c) gain-of-function mutations in STAT1 600555 Genetic defect/Presumed pathogenesis OMIM gene AD AD AR AR AR AD Inheritance Spleen Lymphocytes + Granulocytes + Monocytes Lymphocytes + Granulocytes + Monocytes T cells, fibroblasts T cells, B cells, monocytes Affected Cell RPSA encodes ribosomal protein SA, a component of the small subunit of the ribosome APOL-I TIR-MyD88 signaling pathway TIR-IRAK signaling pathway Fibroblasts fail to respond to IL-17A and IL-17 F, and their T cells to IL-17E Gain-of-function STAT1 mutations that impair the development of IL-17producing T cells Functional Defect Not yet assigned 271400 Bacteremia (encapsulated bacteria) No spleen Trypanosomiasis 612260 607676 615527 614162 Phenotype OMIM Number Bacterial infections (pyogens) Bacterial infections (pyogens) CMC Various fungal, bacterial and viral (HSV) infections Auto-immunity (Thyroiditis, diabetes, cytopenia) Enteropathy CMC Blepharitis, Folliculitis and macroglossia Associated Features XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, NF-κB nuclear factor Kappa B, TIR Toll and Interleukin 1 Receptor, IFN interferon, HVP human papilloma virus, TLR Toll-like receptor, IL interleukin New genes added : RORC, IRF7, IL17RC, APOL-1 Total no. of gene defects in Table 6: 32 8. Trypanosomiasis 9. Isolated congenital asplenia (ICA) MyD88 deficiency IRAK-4 deficiency 8. TLR signaling pathway deficiency ACT1 deficiency STAT1 gain-of-function Disease Table 6 (continued) 720 J Clin Immunol (2015) 35:696–726 Mutations of PSTPIP1 (also called C2BP1) (affects both pyrin and AD AD Pyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA) syndrome PMNs, monocytes AD Mutation (c2120C>A) in PLCG2 (see function defect) 600220 Mutations of TNFRSF1A (resulting in increased TNF inflammatory signaling) 191190 B cells, NK, mast cells AD Mutation in PLCG2 ((see functional defect) 600220 Hematopoietic tissues, upregulated in activated T-cells B cells, NK, Mast cells PMNs monocytes macrophages AD PMNs, chondrocytes PMNs, monocytes PMNs, monocytes Mutation in NLRC4 (see functional defect) 606831 AD AD PMNs Monocytes Mature granulocytes, cytokine-activated monocytes. Affected cells AD (TNF receptor-associated periodic syndrome (TRAPS) PLAID (PLCγ2 associated antibody deficiency and immune dysregulation) Familial cold autoinflammatory syndrome 3 APLAID (autoinflammation and PLCγ2 associated antibody deficiency and immune dysregulation) 2. Non inflammasome-related conditions Neonatal onset multisystem inflammatory disease (NOMID) or chronic infantile neurologic cutaneous and articular syndrome (CINCA) NLRC4-MAS (macrophage activating syndrome) Familial cold autoinflammatory syndrome 4 Familial cold autoinflammatory syndrome 2 Familial cold autoinflammatory syndrome 1 AD AR AR AD Inheritance Mutations of NLRP3 CIAS1 (See above) 606416 Mutations of MVK (lead to a block in the mevalonate pathway. Interleukin-1beta mediates the inflammatory phenotype) 251170 Mutations of NLRP3 (also called NALP3 CIAS1 or PYPAF1) (lead to constitutive activation of the NLRP3 inflammasome) 606416 Mutations of NLRP3 (See above) 606416 Mutations of NLRP12 609648 Mevalonate kinase deficiency (Hyper IgD syndrome) Muckle-Wells syndrome Mutations of MEFV (lead to gain of pyrin function, resulting in inappropriate IL-1β release) 608107 Genetic defect/ Presumed pathogenesis OMIN gene Familial Mediterranean Fever 1. Defects effecting the inflammasome Disease Table 7 Autoinflammatory disorders Mutations of 55-kD TNF receptor leading to intracellular receptor retention or diminished soluble cytokine receptor available to bind TNF Disordered actin reorganization leading to compromised The mutation leads to activation of the NLRP3 inflammasome (not provoked by cold temperature) Gain of function mutation in NLRC4 results in elevated secretion of IL-1β and IL-18 as well as macrophage activation Mutations cause activation of IL-1 pathways same as above same as above same as above Defect in cryopyrin, involved in leukocyte apoptosis and NFkB signaling and IL-1 processing Decreased production of pyrin permits ASCinduced IL-1 processing and inflammation following subclinical serosal injury; macrophage apoptosis decreased. affecting cholesterol synthesis; pathogenesis of disease unclear Functional defects 604416 142680 Recurrent fever, serositis, rash, and ocular or joint inflammation Destructive arthritis, inflammatory skin rash, myositis 614878 614468 616050 616115 Blistering skin lesion, pulmonary and bowel disease Cold urticaria hypogammaglobulinemia Severe enterocolitis and macrophage activation syndrome 607115 611762 120100 191900 Urticaria, SNHL, amyloidosis. Non-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposure. Non-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposure. Neonatal onset rash, chronic meningitis, and arthropathy with fever and inflammation. 260920 249100 134610 Phenotype OMIM number Periodic fever and leukocytosis with high IgD levels Recurrent fever, serositis and inflammation responsive to colchicine. Predisoposes to vasculitis and inflammatory bowel disease. Associated Features J Clin Immunol (2015) 35:696–726 721 Mutation in ADAM17 (leads to tumor necrosis factor α converting enzyme deficiency) 603639 Mutations of LPIN2 (increased expression of the proinflammatory genes) 605519 Mutations of IL1RN (see functional defect) 147679 Mutation in IL36RN (see functional defect) 605507 Mutation in SLC29A3 612373 Mutation in CARD14 (see functional defect) 607211 Mutation in SH3BP2 (see functional defect) 602104 Mutation in PSMB8, (see functional defect) 177046 Mutation in COPA (Coatamer protein complex, subunit alpha) protein tyrosine phosphatase to regulate innate and adaptive immune responses) 606347 Mutations of NOD2 (also called CARD15) (involved in various inflammatory processes) 605956 Genetic defect/ Presumed pathogenesis OMIN gene Neutrophils, bone marrow cells PMNs, Monocytes Keratinocyte Leukocytes AR AR AR Keratinocyte, B cell adipose cells PMNs and tissues specific cells AD Stroma cells, bone cells Mainly in Keratinocyte AR AD AD Leukocyte, bone cells Leukocytes and epithelial cells AR AR Monocytes Affected cells AD Inheritance Mutant COPA leads to defective intracellular transport via the coat protein complex I (COPI) Mutations cause increase IL-6 production Mutations in CARD14 activate the NF-kB pathway and production of IL-8 Hyperactived macrophage and increase NF-kB Hyperpigmentation hypertrichosis Mutations in the IL1 receptor antagonist allow unopposed action of Interleukin 1 Mutations in IL-36RN leads to increase IL-8 production undefined Mutations in nucleotide binding site of CARD15, possibly disrupting interactions with lipopolysaccharides and NF-κB signaling Defective TNFα production physiologic signaling during inflammatory response Functional defects 256040 601924 Autoimmune inflammatory arthritis and interstitial lung disease with Th17 dysregulation and autoantibody production 118400 602723 602782 614204 612852 609628 614328 186580 Phenotype OMIM number Dystrophy, panniculitis Bone degeneration in jaws Histiocytosis-lymphadenopathy plus syndrome Psoriasis Chronic recurrent multifocal osteomyelitis, transfusiondependent anemia, cutaneous inflammatory disorders Neonatal onset of sterile multifocal osteomyelitis, periostitis and pustulosis. Pustular Psoriasis Early onset diarrhea and skin lesions Uveitis, granulomatous synovitis, camptodactyly, rash and cranial neuropathies, 30 % develop Crohn’s disease Associated Features AR autosomal recessive inheritance, AD autosomal dominant inheritance, PMN polymorphonuclear cells, ASC apoptosis-associated speck-like protein with a caspase recruitment domain, CARD caspase recruitment domain, CD2BP1 CD2 binding protein-1, PSTPIP1 Proline/serine/threonine phosphatase-interacting protein 1, SNHL sensorineural hearing loss, CIAS1 cold-induced autoinflammatory syndrome 1 Muckle-Wells syndrome, familial cold autoinflammatory syndrome and neonatal onset multisystem inflammatory disease (NOMID) which is also called chronic infantile neurologic cutaneous and articular syndrome (CINCA) are caused by similar mutations in CIAS1/NLRP3 mutations. The disease phenotype in any individual appears to depend on modifying effects of other genes and environmental factors Notes: Autoinflammatory diseases are clinical disorders marked by abnormally increased inflammation, mediated predominantly by the cells and molecules of the innate immune system, with a significant host predisposition. While the genetic defect of one of the most common autoinflammatory conditions, PFAPA, is not known, recent studies suggest that it is associated with activation of IL-1 pathway and response to IL-1beta antagonists New genes added: NLRC4, ADAM17, COPA Total no. of gene defects in Table 7: 17 CANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy) COPA defect Cherubism CAMPS (CARD14 mediated psoriasis) SLC29A3 mutation Chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia (Majeed syndrome) DIRA (Deficiency of the Interleukin 1 Receptor Antagonist) DITRA – Deficiency of IL-36 receptor antagonist ADAM17 deletion Blau syndrome Disease Table 7 (continued) 722 J Clin Immunol (2015) 35:696–726 Genetic defect; presumed pathogenesis OMIM gene C4B: Classical complement pathway components 120820 C2: Classical complement pathway component 217000 C3: Central complement component 120700 C4 deficiency C2 deficiency C9 deficiency C8β deficiency C8γ deficiency C8 αdeficiency C7 deficiency C6 deficiency C5 deficiency C3 GOF C3 deficiency LOF C4 deficiency C1s deficiency C3: Central complement component 120700 C5: Terminal complement component 120900 C6: Terminal complement component 217050 C7: Terminal complement component 217070 C8A: Terminal complement component 120950 C8G: Terminal complement component 120930 C8B: Terminal complement component 120960 C9: Terminal complement component 120940 C1QC: Classical complement pathway component 120575 C1R: Classical complement pathway component 613785 C1S: Classical complement pathway component 120580 C4A, Classical complement pathway components 120810 C1q deficiency C1r deficiency C1QB: Classical complement pathway component 120570 C1q deficiency 1) Integral complement cascade component deficiencies C1q deficiency C1QA,: Classical complement pathway component 120550 Disease Table 8 Complement deficiencies AR AR AR AR AR AR AR Gain-of-function AD AR AR Absent CH50 and AH50 hemolytic activity Defective bactericidal activity Absent CH50 and AH50 hemolytic activity Defective bactericidal activity Absent CH50 and AH50 hemolytic activity Defective bactericidal activity Absent CH50 and AH50 hemolytic activity Defective bactericidal activity Absent CH50 and AH50 hemolytic activity Defective bactericidal activity Absent CH50 and AH50 hemolytic activity Defective bactericidal activity Reduced CH50 and AP50 hemolytic activity Deficient bactericidal activity Increased activation of complement Absent CH50 and AH50 hemolytic activity Defective opsonization Defective humoral immune response Absent CH50 hemolytic activity, Defective activation of the classical pathway Complete deficiency requires biallelic mutations/deletions/conversions of both C4A and C4B Absent CH50 hemolytic activity, Defective activation of the classical pathway Complete deficiency requires biallelic mutations/deletions/conversions of both C4A and C4B Absent CH50 hemolytic activity, Defective activation of the classical pathway AR AR Absent CH50 hemolytic activity Defective activation of the classical pathway Absent CH50 hemolytic activity, Defective activation of the classical pathway Diminished clearance of apoptotic cells Absent CH50 hemolytic activity, Defective activation of the classical pathway Diminished clearance of apoptotic cells Absent CH50 hemolytic activity, Defective activation of the classical pathway Diminished clearance of apoptotic cells Absent CH50 hemolytic activity, Defective activation of the classical pathway Laboratory features AR AR AR AR AR Inheritance 613652 SLE, infections with encapsulated organisms Mild susceptibility to Neisserial infections Neisserial infections Neisserial infections Neisserial infections Neisserial infections Neisserial infections 613779 Infections; glomerulonephritis; Atypical Hemolytic-uremic syndrome with gain-of-function mutations. Atypical Hemolytic-uremic syndrome Neisserial infections 613825 613789 613790 613790 610102 612446 609536 612925 613927 614379 614380 613783 SLE, infections with encapsulated organisms, atherosclerosis SLE, infections with encapsulated organisms SLE, infections with encapsulated organisms SLE, infections with encapsulated organisms 216950 613652 SLE, infections with encapsulated organisms SLE, infections with encapsulated organisms 613652 Phenotype OMIM number SLE, infections with encapsulated organisms Associated Features J Clin Immunol (2015) 35:696–726 723 FCN3: Activates the classical complement pathway 604973 Ficolin 3 deficiency CFB: Activation of the alternative pathway 138470 CFD: Regulation of the alternative complement pathway 134350 CFP: Regulation of the alternative complement pathway 300383 CFI: Regulation of the alternative complement pathway 217030 CFH: Regulation of the alternative complement pathway 134370 CFHR1-5: Bind C3b 134371 600889 605336 605337 608593 THBD: Regulates complement and coagulant activation 188040 ITGAM 120980 CD46: Dissociates C3b and C4b 120920 CD59: Regulates the membrane attack complex formation 107271 Absent AH50 hemolytic activity Absent AH50 hemolytic activity Spontaneous activation of the alternative complement pathway with consumption of C3 Spontaneous activation of the alternative complement pathway with consumption of C3 AR XL AR Normal CH50, AH50, autoantibodies to Factor H. Linked deletions of one or more CFHR genes leads to susceptibility autoantibody-mediated aHUS Normal CH50, AH50 CR3 expression is lost in LAD1. See LAD1 in Table 5 Inhibitor of complement alternate pathway, decreased C3b binding Erythrocytes highly susceptible to complement-mediated lysis AR/AD AD AR AD AR AR/AD AD Spontaneous activation of the complement pathway with consumption of C4/C2 Spontaneous activation of the contact system with generation of bradykinin from high molecular weight kininogen Gain-of-function mutation with increased spontaneous AH50 Absence of complement activation by the Ficolin 3 pathway. AR AD Deficient activation of the lectin activation pathway Laboratory features AR Inheritance Hemolytic anemia, polyneuropathy aHUS, infections, preeclampsia Infections aHUS aHUS, Neisserial infections 610984 612923 Infections, Neisserial infections, aHUS, preeclampsia Infections, Neisserial infections, aHUS, preeclampsia 612300 612922 609939 612926 235400 609814 235400 312060 613912 612924 106100 613860 613791 Phenotype OMIM number Neisserial infections Neisserial infections aHUS Hereditary angioedema Pyogenic infections; Inflammatory lung disease, autoimmunity Respiratory infections, abscesses Associated Features XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, MAC membrane attack complex, SLE systemic lupus erythematosus, MASP MBP associated serine protease 2 No new genes added to the 2015 classification Total no. of genes Tables 8 and 9: 30 Membrane Attack Complex Inhibitor (CD59) deficiency Complement Receptor 3 (CR3) deficiency Membrane Cofactor Protein (CD46) deficiency Thrombomodulin Factor H –related protein deficiencies Factor H deficiency Factor I deficiency Properdin deficiency Factor D deficiency Factor B 2) Complement Regulatory defects C1 inhibitor deficiency SERPING1: regulation of kinins and complement activation 606860 MASP2: Cleavage of C4 605102 Genetic defect; presumed pathogenesis OMIM gene MASP2 deficiency Disease Table 8 (continued) 724 J Clin Immunol (2015) 35:696–726 Decreased naive T cells AutoAb to IFN gamma AutoAb to IL-6 AutoAb to GM-CSF AutoAb to CI inhibitor AutoAb to Complement Factor H Pulmonary alveolar proteinosis Acquired angioedema Atypical Hemolytic Uremic Syndrome Normal Normal Normal Normal Normal Germline mutation in AIRE AutoAb to IL-17 and/or IL-22 Somatic mutation in NLRP3 Increased CD4−CD8−double negative (DN) T alpha/beta cells Normal Somatic mutation in NRAS (gain-offunction) Recurrent skin infection RAS-associated autoimmune leukoproliferative disease (RALD) Cryopyrinopathy, (MuckleWells /CINCA/NOMIDlike syndrome) Associated with autoantibodies Chronic mucocutaneous candidiasis (isolated or with APECED syndrome) Adult-onset immunodeficiency Normal Increased CD4−CD8−double negative (DN) T alpha/beta cells Circulating T cells Somatic mutation in KRAS (gain-of-function) Somatic mutation in TNFRSF6 Associated with somatic mutations Autoimmune lymphoproliferative syndrome (ALPS–SFAS) RAS-associated autoimmune leukoproliferative disease (RALD) Genetic defect/presumed pathogenesis Disease Table 9 Phenocopies of PID Normal Normal Normal Normal Normal Normal Normal Lymphocytosis B cell lymphocytosis Normal, but increased number of CD5+ B cells Circulating B cells Normal Normal Normal Normal Normal Normal Normal Normal or increased Normal or increased Serum Ig Pulmonary alveolar proteinosis, cryptococcal meningitis/CSF2RA deficiency Angioedema/C1 INH deficiency (hereditary angioedema) aHUS Spontaneous activation of the alternative complement pathway Mycobacterial, fungal, Salmonella VZV infections/MSMD, or CID Staphylococcal infections/STAT3 deficiency Endocrinopathy, chronic mucocutaneous candidiasis/CMC Urticaria-like rash, arthropathy, neurological symptoms Splenomegaly, lymphadenopathy, autoimmune cytopenias, granulocytosis, monocytosis/ ALPS-like Splenomegaly, lymphadenopathy, autoantibodies/ALPS-like Splenomegaly, lymphadenopathy, autoimmune cytopenias Defective lymphocyte apoptosis/ ALPS–FAS (=ALPS type Im) Associated features/similar PID J Clin Immunol (2015) 35:696–726 725 726 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. J Clin Immunol (2015) 35:696–726